Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 641 - 650 of 785 studies

Neurological Reproductive health and childbirth

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with an Open-Label Extension to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Preventive Treatment of Menstrual Migraine

A Prospective, Screening Study of Bleeding and Treatment in Participants with Von Willebrand Disease

SAIL Research Database (SAIL)

Cancer and neoplasms

A Phase 1-2 Master Protocol to Study ATTR-01 in Participants with Selected Advanced Solid Tumours (ATTEST)

Cancer and neoplasms

A Phase 3, randomized, open-label, multicenter, controlled study to evaluate the efficacy and safety of zanidatamab in combination with physician’s choice chemotherapy compared to trastuzumab in combination with physician’s choice chemotherapy for the treatment of participants with metastatic HER2-positive breast cancer who are ineligible for, intolerant to, or have progressed on previous trastuzumab deruxtecan treatment (EmpowHER 303)

Pleural blood patch for lung ablation: a randomized trial (Oxford Pleural Embolisation Trial - OxPET) (OxPET)

Non-invasive assessment of air leak in pneumothorax using Hyperpolarised Xenon MRI (NoVANT)

Follow-up of the Long-term Outcomes of WomEn with cardiovascular conditions in pRegnancy (FLOWER)

Cancer and neoplasms

A Phase I/II Open-Label Multi-Centre Master Protocol to Evaluate the Safety and Efficacy of AZD0486 Monotherapy or in Combination with Other Anticancer Agents in Participants with Mature B-Cell Malignancies (SOUNDTRACK-E)

Cancer and neoplasms

A Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 or 2 systemic treatment regimens (CHONQUER (CL3-95031-007))